Christoph Markert, MD, is a Translational Medicine Leader in Oncology at Roche, where they have been contributing to Pharma Research & Early Development (pRED) since 2019. Prior to joining Roche, they served as an Associate Medical Director and Senior Medical Advisor in Oncology at Bristol-Myers Squibb from 2016 to 2019. Christoph earned their Doctor of Medicine (MD) from The Julius Maximilians University of Würzburg between 2000 and 2007 and completed a Board certification in Clinical Pharmacology at the University of Heidelberg in 2013. Their early education culminated at Julius-Echter-Gymnasium Elsenfeld, where they graduated high school in 1999.
This person is not in the org chart
This person is not in any teams
This person is not in any offices